Particularly, PABPC1 presented the second highest reduction in the MTT assay next to small nuclear ribonucleoprotein polypeptide E (SNRPE), and its transcript level was elevated in many cancer types including breast cancer (Fig. 6C). This evidence concerns the gene PABPC1 and breast cancer.